Frankfurt
30.12.25 | 13:55
0,017 Euro
-1,71 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 06.11. | Acarix AB Q3 Loss Drops | 3 | RTTNews | ||
| 06.11. | Acarix Q3 2025: Umsatzplus von 137 % beflügelt globalen Expansionskurs | 5 | Investing.com Deutsch | ||
| 06.11. | Acarix Q3 2025 presentation slides: 137% revenue growth amid global expansion | 3 | Investing.com | ||
| 06.11. | Acarix AB: Acarix Publishes Interim Report, Third quarter 2025 | 102 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the third quarter of 2025. The report highlights international... ► Artikel lesen | |
| 27.10. | Acarix AB: Announcement from the general meeting in Acarix AB | 179 | GlobeNewswire (Europe) | The extraordinary general meeting 2025 (the "EGM") of Acarix AB ("Acarix" or the "Company") was held today on 27 October 2025 and the following resolutions were passed unanimously by the meeting.
Change... ► Artikel lesen | |
| ACARIX Aktie jetzt für 0€ handeln | |||||
| 17.10. | Acarix AB: Acarix responds to G-BA decision on reimbursement in the German market | 189 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, today announce that G-BA reached a negative decision on the possibility for CADScor System to receive reimbursement... ► Artikel lesen | |
| 21.08. | Acarix AB: Acarix Reports Significant Progress Toward Fixed Reimbursement | 193 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that the company has achieved another milestone on its path toward fixed reimbursement... ► Artikel lesen | |
| 21.08. | Acarix AB: Acarix Publishes Interim Report, January - June 2025 | 180 | GlobeNewswire (Europe) | Malmö, Sweden (Aug. 21, 2025) - Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the second quarter and first half of 2025. The... ► Artikel lesen | |
| 28.07. | Acarix AB: Acarix achieves new Fixed U.S. reimbursement milestone for CADScor at $300.00 USD | 275 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a global leader in AI- and acoustics-based cardiac diagnostics, is pleased to announce that a second payer has agreed to provide fixed reimbursement of $300 for the CADScor®... ► Artikel lesen | |
| 08.07. | Acarix AB: Acarix Enters MENA Region with First Major Order, Expanding Global Presence | 282 | GlobeNewswire (Europe) | Malmö, Sweden - July 8, 2025 - Acarix, a global pioneer in AI-driven and acoustics-based cardiac diagnostics, is proud to announce its first order in the Middle East and North Africa (MENA) region.... ► Artikel lesen | |
| 26.06. | Acarix AB: Acarix Applauds New Peer-Reviewed Study Demonstrating Cost-Effectiveness of the CADScor System in U.S. Emergency Departments | 280 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix, a leader in non-invasive cardiac diagnostics, is pleased to announce the publication of a new peer-reviewed study in PharmacoEconomics - Open demonstrating that the CADScor®... ► Artikel lesen | |
| 16.06. | Acarix AB: Acarix Achieves First Fixed U.S. Reimbursement Milestone for CADScor at $300.00 USD | 265 | GlobeNewswire (Europe) | Malmö, Sweden - Acarix a global leader in AI and acoustics-based cardiac diagnostics, is pleased to announce that the first payor has agreed to provide fixed reimbursement for the CADScor® System at... ► Artikel lesen | |
| 12.05. | Acarix AB: Acarix Publishes Interim Report, January - March 2025 | 365 | GlobeNewswire (Europe) | Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today announced its interim financial results for the first quarter of 2025. The report highlights continued growth in the U.S.... ► Artikel lesen | |
| 13.02. | Acarix Publishes Year-End Report 2024 - Sales and revenue for the CADScor System and patches are surging amid ongoing U.S. expansion efforts | 378 | PR Newswire | OKLAHOMA CITY, Feb. 13, 2025 /PRNewswire/ -- Acarix, a leader in rapid AI and acoustics-based cardiac diagnostics, today reported its 2024 year-end financial results. "The company continues... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 40,760 | +0,37 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 40,000 | -1,57 % | EILMELDUNG: Carl Zeiss Meditec-Aktie tritt auf der Stelle - Anleger warten auf das nächste Signal. | ||
| ECKERT & ZIEGLER | 15,260 | -0,13 % | EILMELDUNG: Eckert&Ziegler-Aktie auf Höhenflug - Anleger feiern starkes Comeback! | ||
| UNITEDHEALTH | 280,10 | +0,23 % | ROUNDUP/Aktien New York: Kaum verändert am vorletzten Handelstag des Jahres | NEW YORK (dpa-AFX) - Bei den wichtigsten US-Aktienindizes hat sich am Dienstag am vorletzten Handelstag des Jahres wenig getan. Der Dow Jones Industrial sank im frühen Handel um 0,08 Prozent auf 48.423... ► Artikel lesen | |
| HIMS & HERS HEALTH | 29,040 | +0,24 % | HIMS Scales AI-Enabled Care as Platform Depth and Engagement Expand | ||
| BICO GROUP | 1,925 | +5,25 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,018 | -5,38 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| SPINEWAY | 0,143 | -4,79 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| UNIDOC HEALTH | 0,101 | +7,59 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| VERU | 2,180 | -1,36 % | Veru Inc.: Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress | -- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in combination with GLP-1 RA -- -- Incremental weight loss is an... ► Artikel lesen | |
| CLARIANE | 3,848 | +0,37 % | Korian Stiftung zeichnet Pflegedienst vielfältig. GmbH, Bremen, mit dem Award für Vielfalt und Respekt in der Pflege 2025 aus | Berlin (ots) - Die Korian Stiftung für Pflege und würdevolles Altern hat am Freitagabend im Lebensort Vielfalt in Berlin den Korian Stiftungsaward für Vielfalt und Respekt in der Pflege 2025 verliehen.... ► Artikel lesen | |
| SENSEONICS | 4,760 | -1,24 % | XFRA 6L60: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| VIROMED MEDICAL | 3,800 | +5,56 % | VIROMED MEDICAL AG: Jetzt kippt die Stimmung - handeln! | ||
| BONESUPPORT | 17,280 | -1,31 % | Bonesupport Holding AB: Bonesupport Holding AB (publ) - Publishes Q3 2025 Interim Report | BONESUPPORT HOLDING AB (publ), a leading company in orthobiologics for the management of bone injuries, today publishes the interim report for the third quarter 2025.
"Solid growth and new clinical... ► Artikel lesen |
Das Unternehmen ACARIX AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell -1,71 % bei einem Aktienkurs von 0,017 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ACARIX AB finden Sie auf Wallstreet Online.